Top asthma drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

Loading statistic...
Revenue in million U.S. dollars
Singulair4,940.6
Advair Diskus4,559.6
Spiriva Handihaler2,588.8
Combivent1,131.6
Symbicort1,131.5
Proair HFA1,035.5
Flovent HFA975.4
Budesonide923.2
Ventolin HFA655.6
Xolair591

© Statista 2017

Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Description Source More information
This statistic represents the top asthma drugs in the United States, based on revenue between July 2011 and June 2012. In this period, the asthma drug Singulair generated around 4.9 billion U.S. dollars of revenues.
Show more
Release date
August 2012
Region
United States
Survey time period
July 2011 to June 2012

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "Top pharmaceutical drugs"

  • Global overview
  • Select therapy classes - global
The most important statistics
  • U.S. overview
The most important statistics
  • Select therapy classes - U.S.

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions